Misoprostol Versus Pitocin for Induction of Labor in Patients With BMI > 30: A Randomized Controlled Trial
Icahn School of Medicine at Mount Sinai
Summary
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Description
This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.
Eligibility
- Age range
- 18+ years
- Sex
- Female
- Healthy volunteers
- No
Inclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30 Exclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30
Interventions
- DrugMisoprostol
25 mcg vaginally every 6 hours
- DrugPitocin
3-6 mL intravenously every hour
Locations (2)
- Mount Sinai HospitalNew York, New York
- Bronx Care Health SystemThe Bronx, New York